Shane William Charles Kovacs, Chief Financial Officer at PTC THERAPEUTICS, INC. (PTCT), sold 82,491 shares at $55.93 ($4.6M) on 2015-05-22, disclosed to the SEC on 2015-05-22.
Scheduled sale ($4.6M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.26 | 64,041 | $3.5M | 77.4% |
| 2 | $55.93 | 18,450 | $1.0M | 22.6% |
| Total | $55.41 avg | 82,491 | $4.6M | 100% |
| Filing → |
| OLMA | SELL | 2023-11-22 | $529K | — | Filing → |
| PTCT | SELL | 2014-05-23 | $24K | — | Filing → |